Immunoclin (Immunoclin) LT-Debt-to-Total-Asset : 0.00 (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Immunoclin's long-term debt to total assests ratio for the quarter that ended in Oct. 2014 was 0.00.

Immunoclin's long-term debt to total assets ratio stayed the same from Aug. 2013 (0.00) to Oct. 2014 (0.00).

Immunoclin LT-Debt-to-Total-Asset Historical Data

The historical data trend for Immunoclin's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin LT-Debt-to-Total-Asset Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

LT-Debt-to-Total-Asset

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin LT-Debt-to-Total-Asset Calculation

Immunoclin's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2014 is calculated as

LT Debt to Total Assets (A: Jan. 2014 )	=	Long-Term Debt & Capital Lease Obligation (A: Jan. 2014 )	/	Total Assets (A: Jan. 2014 )
	=	0	/	21.039
	=

Immunoclin's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2014 is calculated as

LT Debt to Total Assets (Q: Oct. 2014 )	=	Long-Term Debt & Capital Lease Obligation (Q: Oct. 2014 )	/	Total Assets (Q: Oct. 2014 )
	=	0	/	20.391
	=	0.00

Immunoclin (GREY:IMCL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Immunoclin LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Immunoclin's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines